21 May 2026
Innovations in TAVI: TAVI 2.0
Session comprising selected EuroPCR 2026 abstract submissions
Summary
This session presents cutting-edge advancements in transcatheter aortic valve implantation (TAVI), highlighting the TAVI 2.0 era. It encompasses innovative techniques such as percutaneous and non-fluoroscopic TAVR guided by transthoracic echocardiography (TTE), novel alternative access via the left subscapular approach, and patient-tailored commissural alignment assessed through CT follow-up studies. Further topics include the feasibility of TAVI guided solely by transesophageal echocardiography (TEE), artificial intelligence analysis of left ventricular ejection fraction post valve-in-valve implantation, and digitally enhanced patient management strategies to predict redo TAVI procedures.